2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P991502
    Armenian hamster IgG1 kappa, Isotype Control 98%
    Armenian hamster IgG1 kappa, Isotype Control, a Armenian hamster monoclonal antibody, is an isotype control for Armenian hamster IgG1 kappa antibody.
    Armenian hamster IgG1 kappa, Isotype Control
  • HY-RS16311
    Herc6 Mouse Pre-designed siRNA Set A 98%
    Herc6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Herc6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Components
    Herc6 Mouse Pre-designed siRNA Set A-1
    Herc6 Mouse Pre-designed siRNA Set A-2
    Herc6 Mouse Pre-designed siRNA Set A-3
    siRNA Negative Control
    FAM-labeled siRNA Negative Control
    GAPDH Positive Control siRNA (Mouse)
    Herc6 Mouse Pre-designed siRNA Set A
  • HY-RS29448
    ILF2 Pig Pre-designed siRNA Set A 98%
    ILF2 Pig Pre-designed siRNA Set A contains three designed siRNAs for ILF2 gene (Pig), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Components
    ILF2 siRNA-1: 5 nmol (HPLC)
    ILF2 siRNA-2: 5 nmol (HPLC)
    ILF2 siRNA-3: 5 nmol (HPLC)
    siRNA Negative Control: 5 nmol (HPLC)
    FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
    GAPDH siRNA Positive Control: 5 nmol (HPLC)
    ILF2 Pig Pre-designed siRNA Set A
  • HY-U00098R
    Prednisolone Tebutate (Standard) 7681-14-3
    Prednisolone Tebutate (Standard) is the analytical standard of Prednisolone Tebutate. This product is intended for research and analytical applications. Prednisolone tebutate is a synthetic glucocorticoid used as an antiinflammatory and immunosuppressant.
    Prednisolone Tebutate (Standard)
  • HY-U00103R
    Triamcinolone hexacetonide (Standard) 5611-51-8
    Triamcinolone hexacetonide (Standard) is the analytical standard of Triamcinolone hexacetonide. This product is intended for research and analytical applications. Triamcinolone hexacetonide is a commonly used long-acting steroids in treatment of subacute and chronic inflammatory joint diseases.
    Triamcinolone hexacetonide (Standard)
  • HY-U00432B
    S-MTC acetate 174063-92-4 98%
    S-MTC acetate (S-Methyl-L-thiocitrulline acetate) acts as a powerful inhibitor of inducible nitric oxide synthase, favoring the inhibition of constitutive (neuronal) nitric oxide synthase over inducible (endothelial) nitric oxide synthase.
    S-MTC acetate
  • HY-U00450R
    4-O-Methyl honokiol (Standard) 68592-15-4
    4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.
    4-O-Methyl honokiol (Standard)
  • HY-W009121
    Cbz-D-Trp-OH 2279-15-4 98.26%
    Cbz-D-Trp-OH is a competitive inhibitor of SCD, with IC50 of 86 μM and Ki of 71 μM.
    Cbz-D-Trp-OH
  • HY-W011197
    Cbz-L-Trp-OH 7432-21-5 99.83%
    Cbz-L-Trp-OH is a competitive inhibitor of SCD, with an IC50 of 2.5 μM and a Ki of 2.1 μM.
    Cbz-L-Trp-OH
  • HY-W011340
    5-Hydroxy flunixin 75369-61-8 98%
    5-Hydroxy flunixin, the principal metabolite of Flunixin (HY-121046), retains the Flunixin's anti-inflammatory properties and plays a significant role in mitigating pain and inflammation in various veterinary applications. It assists in alleviating conditions such as colic in horses, musculoskeletal disorders, and infectious diseases in cattle, while also supporting the management of mastitis-metritis-agalactia syndrome in sows.
    5-Hydroxy flunixin
  • HY-W013007
    4-Hexen-3-one 2497-21-4 98%
    4-Hexen-3-one inhibits the growth of H. pylori strain ATCC 43526 and TDR H. pylori strains. 4-Hexen-3-one inhibits urease activities.
    4-Hexen-3-one
  • HY-W013331
    Deoxyartemisinin 72826-63-2 99.9%
    Deoxyartemisinin, a orally bioavailable compound separated from Artemisinin annua L., shows anti-inflammatory and antiulcer activities.
    Deoxyartemisinin
  • HY-W016181
    Phenylhydroquinone 1079-21-6 99.21%
    Phenylhydroquinone (PHQ) is an orally active thymic atrophy inducer which can up-regulate apoptosis through activation of p53. PHQ can be used for research of thymic atrophy.
    Phenylhydroquinone
  • HY-W028263
    6-Hydroxyflavanone 4250-77-5 99.87%
    6-Hydroxyflavanone is a compound that can be isolated from the Muntingia calabura leaves. 6-Hydroxyflavanone targets cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and opioid and GABA-A receptors that has anti-inflammatory and anti-neuropathic pain potential. 6-Hydroxyflavanone can be used for the research of diabetes.
    6-Hydroxyflavanone
  • HY-W046063
    O-Phthalimide-C3-acid 3130-75-4 98%
    4-(N-Phthalimidoyl)butanoic acid (compound FB) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-(N-Phthalimidoyl)butanoic acid can be combined with carrier proteins and used in antigen design.
    O-Phthalimide-C3-acid
  • HY-W071581
    Glucocorticoid receptor activator 1 14593-25-0 98%
    Glucocorticoid receptor activator 1 (compound A) is a phenyl aziridine precursor and an activator of the glucocorticoid receptor (GR). Glucocorticoid receptor activator 1 down-modulates TNF-induced pro-inflammatory gene expression by activating GR and can be utilized in inflammation research.
    Glucocorticoid receptor activator 1
  • HY-W074888
    N-Lauroyl-L-glutamic acid 3397-65-7 98%
    N-Lauroyl-L-glutamic acid is an amino acid derivative with anti-asthmatic activity. N-Lauroyl-L-glutamic acid has been found to improve asthma symptoms in studies. The potential application of N-Lauroyl-L-glutamic acid is mainly focused on the suppression of respiratory diseases. N-Lauroyl-L-glutamic acid may help improve the quality of life of patients.
    N-Lauroyl-L-glutamic acid
  • HY-W095499
    Corydaldine 493-49-2 98%
    Corydaldine is a alkaloid. Corydaldine inhibits the production of NO in the BV2 cell line when stimulated by LPS.[1]
    Corydaldine
  • HY-W099582
    Myristamidopropyl dimethylamine 45267-19-4 98%
    Myristamidopropyl dimethylamine (MAPD) is an antimicrobial agent (including against bacteria and fungi) and an insecticide, exhibiting inhibitory activity against Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, Fusarium solani, and Acanthamoeba polyphaga. Myristamidopropyl dimethylamine can be used in research on microbial-induced keratitis .
    Myristamidopropyl dimethylamine
  • HY-W104752
    5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol 15264-63-8 99.34%
    5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol (Compound 3n) is an antimicrobial and antioxidant agent, that inhibits Escherichia coli and Staphylococcus epidermidis, with MIC of 8 and 4 μg/mL. 5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol exhibits antioxidant activity with IC50 of 17.47 μM using DPPH free radical-scavenging method.
    5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol
Cat. No. Product Name / Synonyms Application Reactivity